A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia
NCT02968472
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
B Acute Lymphoblastic Leukemia
Interventions
GENETIC:
prophylactic 4SCAR19 cells
Sponsor
The First People's Hospital of Yunnan
Collaborators
[object Object]